ketotifen has been researched along with Respiratory Tract Diseases in 3 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Respiratory Tract Diseases: Diseases involving the RESPIRATORY SYSTEM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of Ketotifen was examined in the treatment of 113 infants between 6 and 36 months of age presenting with a history of cough and/or wheeze in a multicentre randomized placebo-controlled double-blind study." | 9.07 | A multicentre randomized placebo-controlled double-blind study on the efficacy of Ketotifen in infants with chronic cough or wheeze. ( Gibbeson, M; Harris, M; Harth, SC; Loh, RK; McKay, KO; Mellis, CM; Rhodes, L; Robertson, IF; Thong, YH; van Asperen, PP, 1992) |
| "The efficacy of Ketotifen was examined in the treatment of 113 infants between 6 and 36 months of age presenting with a history of cough and/or wheeze in a multicentre randomized placebo-controlled double-blind study." | 5.07 | A multicentre randomized placebo-controlled double-blind study on the efficacy of Ketotifen in infants with chronic cough or wheeze. ( Gibbeson, M; Harris, M; Harth, SC; Loh, RK; McKay, KO; Mellis, CM; Rhodes, L; Robertson, IF; Thong, YH; van Asperen, PP, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Medici, TC | 1 |
| Radielovic, P | 1 |
| Steiner, A | 1 |
| Nagai, H | 1 |
| Kawasaki, H | 1 |
| Takeda, H | 1 |
| Takaoka, Y | 1 |
| Inagaki, N | 1 |
| van Asperen, PP | 1 |
| McKay, KO | 1 |
| Mellis, CM | 1 |
| Loh, RK | 1 |
| Harth, SC | 1 |
| Thong, YH | 1 |
| Harris, M | 1 |
| Robertson, IF | 1 |
| Gibbeson, M | 1 |
| Rhodes, L | 1 |
2 trials available for ketotifen and Respiratory Tract Diseases
| Article | Year |
|---|---|
[Short-term effect of ketotiphen on physicochemical sputim characteristics in patients with chronic reversible respiratory diseases].
Topics: Adult; Aged; Drug Administration Schedule; Female; Fucose; Glycoproteins; Humans; Immunoglobulin A; | 1980 |
A multicentre randomized placebo-controlled double-blind study on the efficacy of Ketotifen in infants with chronic cough or wheeze.
Topics: Child, Preschool; Chronic Disease; Cough; Double-Blind Method; Female; Humans; Infant; Ketotifen; Ma | 1992 |
1 other study available for ketotifen and Respiratory Tract Diseases
| Article | Year |
|---|---|
The effect of a TXA2 receptor antagonist ON-579 on experimental allergic reactions.
Topics: Aerosols; Airway Resistance; Animals; Antigens; Arthus Reaction; Bronchoalveolar Lavage Fluid; Conca | 1995 |